The price characteristics of the domestic pharmaceutical market of medicines of the N06BX group (other psychostimulants and nootropics)
DOI:
https://doi.org/10.24959/uekj.20.31Keywords:
market analysis, price situation, cerebroprotectors, solvency adequacy ratio, liquidity ratioAbstract
Aim. To study the price characteristics of the domestic pharmaceutical market of medicines of the N06BX group, as well as analyze their socioeconomic accessibility for consumers.
Results. The study used a concept based on a step-by-step analysis of the range and price situation of medicines of the N06BX group by the following indicators: liquidity ratio, adequate solvency ratio and availability ratio. It has been found that the vast majority of medicines in this group have a liquidity ratio not exceeding 0.5, while in 76 % of drugs this figure does not exceed 0.2, i.e. the level of competition in this market segment is quite high, and it contributes to price reduction. Only two medicines are characterized by low competition, these are Phenibut (0.68) and Glycine (1.5). When studying the values of the solvency adequacy ratio its range has been determined, it is from 0.002 to 0.318. The lowest value is observed in Quanil solution for oral administration (Ca.s = 0.002) and Piracetam (Ca.s = 0.003). These medicines are the most available to the population. The highest value is observed in Cerebrocurin (Ca.s = 0.318), i.e. it is the least available in this group.
Conclusions. As a result of our research, it has been determined that at the pharmaceutical market of Ukraine medicines from the N06BX group are presented in the number of 214 names. The values of the liquidity ratio calculated by us have shown that the market segment studied is characterized by strong competition, and it contributes to price reduction. The study of the values of the solvency adequacy ratio obtained has allowed us to determine that the lowest value is observed in Piracetam (Ca.s = 0.003), while the highest one is in Cerebrocurin (Ca.s = 0.318). According to our research, 25 % of the drugs studied have the value Ca.s, which is ≤ 0.01, i.e. the price does not exceed 1 % of the average wage, and the socioeconomic accessibility indicator CD is equal to 0.99. These drugs are the most available to the population.References
Zhang, W., Huang, Y., Li, Y., Tan, L., Nao, J., Hu, H., Zhang, J., Li, C., Kong, Y., Song, Y. (2016). Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial. Clinical drug investigation, 36 (9), 697–704. doi: https://doi.org/10.1007/s40261-016-0415-x.
World Health Organization. Available at: http://www.who.int/en/.
Wirtz, V. J., Kaplan, W. A., Kwan, G. F., Laing, R. O. (2016). Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation, 133 (21), 2076–2085. doi: https://doi.org/10.1161/CIRCULATIONAHA.115.008722.
Departament Okhorony Zdorovia Chernivetskoi ODA. Available at: https://www.medcv.gov.ua/archives/9042.
Kosiachenko, K. L., Nemchenko, A. S., Kovalenko, O. V., Kubarieva, I. V. (2011). Farmatsevtychnyi zhurnal, 1, 13-18.
Nemchenko, A. S., Kurylenko, Yu. Ye. (2018) Farmatsevtychnyi chasopys, 2, 77-81. doi: 10.11603/2312-0967.2018.2.9086.
Nemchenko, A. S., Zharkova, S. O., Podhaina, M. V. (2012). Upravlinnia, ekonomika ta zabezpechennia yakosti farmatsii, 4, 60-64.
Redkina, Ye. A., Tkachenko, N. O., Hladyshev, V. V., Pukhalska, I. O. (2017). Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 2 (24), 207-213. doi: 10.14739/2409-2932.2017.2.10377.
Burlaka, B. S., Belienichev, I. F., Sincha, N. M., Sincha, K. A., Al Zedan Fadi. (2020). Upravlinnia, ekonomika ta zabezpechennia yakosti farmatsii, 3 (63), 68-74. doi: 10.24959/uekj.20.25.
Derzhavnyi reiestr likarskykh zasobiv Ukrainy. Available at: http://www.drlz.kiev.ua.
Derzhavnyi komitet statystyky Ukrainy. Available at: http://www.ukrstat.gov.ua.
Nemchenko, A. S., Kosiachenko, K. L., Nemchenko, O. A. (2012). Tsinoutvorennia na likarski zasoby. Kharkiv: Apostrof, 304.
Nemchenko, A. S., Balynska, M. V. (2017). Sotsialna farmatsiia v okhoroni zdorovia, 3 (2), 70-79. doi: 10.24959/sphhcj.17.75.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
